default author photo

Jing Huang

Chinese Academy of Medical Sciences - Cancer Hospital

No 17 Panjiayuan N

Chaoyang District

Beijing, 100021

China

SCHOLARLY PAPERS

2

DOWNLOADS

278

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Anlotinib for Previously Treated Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (ALTER1102): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

Number of pages: 26 Posted: 28 Jul 2019
Chinese Academy of Medical Sciences - Cancer Hospital, Xi'an Jiaotong University (XJTU) - First Affiliated Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Xinxiang Medical University - First Affiliated Hospital, Zhengzhou University - First Affiliated Hospital, Nanjing Medical University - First Affiliated Hospital, Nanjing Medical University - Jiangsu Institute of Cancer Research, Shandong University - Shandong Cancer Hospital, Tianjin Cancer Hospital, Nanjing Medical University - Department of Epidemiology and Biostatistics, Zhengzhou University - Henan Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Harbin Medical University - Cancer Hospital, Xinjiang Medical University - Affiliated Tumor Hospital, Chinese Academy of Medical Sciences - Department of Medical Oncology and Chinese Academy of Medical Sciences & Peking Union Medical College - Thoracic Surgery Department
Downloads 183 (413,774)

Abstract:

Loading...

esophageal squamous cell carcinoma; metastatic; anlotinib; survival; progression-free survival; adverse events

2.

Randomized Controlled Trial of Irinotecan Plus S-1 for Pretreated Patients with Advanced Esophageal Squamous Cell Carcinoma

Number of pages: 66 Posted: 24 Sep 2018
Chinese Academy of Medical Sciences - Cancer Hospital, Chinese Academy of Medical Sciences - Department of Medical Oncology, Zhengzhou University - Henan Cancer Hospital, Chinese Academy of Medical Sciences - Peking Union Medical College, Xinxiang Medical University - First Affiliated Hospital, Tianjin Cancer Hospital, Central South University - Hunan Cancer Hospital, Harbin Medical University - Cancer Hospital, Shandong University - Shandong Cancer Hospital, Nanjing Medical University - Jiangsu Institute of Cancer Research, Jilin Cancer Hospital, Shanxi Cancer Hospital, Shanxi Cancer Hospital, Huazhong University of Science and Technology - Department of Oncology, Chifeng Municipal Hospital, Central South University - Second Xiangya Hospital, Zhengzhou University - First Affiliated Hospital and Chinese Academy of Medical Sciences - Peking Union Medical College
Downloads 95 (715,072)

Abstract:

Loading...

Esophageal Squamous Cell Carcinoma; Irinotecan; S-1